365 related articles for article (PubMed ID: 34122056)
1. Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis.
Shen NN; Zhang C; Hang Y; Li Z; Kong LC; Wang N; Wang JL; Gu ZC
Front Pharmacol; 2021; 12():581293. PubMed ID: 34122056
[No Abstract] [Full Text] [Related]
2. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Ozaki AF; Choi AS; Le QT; Ko DT; Han JK; Park SS; Jackevicius CA
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005969. PubMed ID: 32148102
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis.
Pereira MQ; David C; Almeida AG; Brito D; Pinto FJ; Caldeira D
Int J Cardiol; 2022 Sep; 362():76-82. PubMed ID: 35513121
[TBL] [Abstract][Full Text] [Related]
4. An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation.
Shen NN; Ferroni E; Amidei CB; Canova C; Peron V; Wang JL; Lin HW; Gu ZC
Clin Appl Thromb Hemost; 2023; 29():10760296231179439. PubMed ID: 37264798
[TBL] [Abstract][Full Text] [Related]
5. Direct oral anticoagulants and the risk of osteoporotic fractures in patients with non-valvular atrial fibrillation.
Kuo LT; Lin SJ; Wu VC; Chang JJ; Chu PH; Lin YS
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211011374. PubMed ID: 33995605
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
[TBL] [Abstract][Full Text] [Related]
7. Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data.
Warkentin L; Hueber S; Deiters B; Klohn F; Kühlein T
Thromb J; 2022 May; 20(1):31. PubMed ID: 35619140
[TBL] [Abstract][Full Text] [Related]
8. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
[TBL] [Abstract][Full Text] [Related]
9. Oral Anticoagulation in Patients in the Emergency Department: High Rates of Off-Label Doses, No Difference in Bleeding Rates.
Eschler CM; Woitok BK; Funk GC; Walter P; Maier V; Exadaktylos AK; Lindner G
Am J Med; 2020 May; 133(5):599-604. PubMed ID: 31668901
[TBL] [Abstract][Full Text] [Related]
10. Impact of direct oral anticoagulant off-label doses on clinical outcomes of atrial fibrillation patients: A systematic review.
Santos J; António N; Rocha M; Fortuna A
Br J Clin Pharmacol; 2020 Mar; 86(3):533-547. PubMed ID: 31631392
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study.
Miyazaki M; Matsuo K; Uchiyama M; Nakamura Y; Sakamoto Y; Misaki M; Tokura K; Jimi S; Okamura K; Adachi S; Yamamoto T; Shirai K; Urata H; Imakyure O
J Pharm Health Care Sci; 2020; 6():2. PubMed ID: 32071730
[TBL] [Abstract][Full Text] [Related]
12. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study.
Lau WCY; Cheung CL; Man KKC; Chan EW; Sing CW; Lip GYH; Siu CW; Lam JKY; Lee ACH; Wong ICK
Ann Intern Med; 2020 Jul; 173(1):1-9. PubMed ID: 32423351
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation.
Rymer JA; Chiswell K; Young L; Chiu A; Liu L; Webb L; Carlisle M; Friedman D; Wang TY
JAMA Netw Open; 2023 Jun; 6(6):e2317156. PubMed ID: 37285155
[TBL] [Abstract][Full Text] [Related]
14. Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation.
Gustafson WL; Saunders J; Vazquez SR; Jones AE; Witt DM
Pharm Pract (Granada); 2019; 17(4):1709. PubMed ID: 31897264
[TBL] [Abstract][Full Text] [Related]
15. Trends in anticoagulant prescribing: a review of local policies in English primary care.
Ho KH; van Hove M; Leng G
BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.
Draper E; Parkhurst B; Carley B; Krueger K; Larson T; Griesbach S
Am J Cardiovasc Drugs; 2017 Dec; 17(6):475-479. PubMed ID: 28887621
[TBL] [Abstract][Full Text] [Related]
17. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States.
Sandhu A; Kaltenbach LA; Chiswell K; Shimoga V; Ashur C; Pribish A; Fonarow GC; Piccini JP; Ho PM; Varosy PD; Hess PL
Circ Cardiovasc Qual Outcomes; 2023 Dec; 16(12):e010062. PubMed ID: 37929603
[TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R
BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961
[No Abstract] [Full Text] [Related]
19. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
Wu M; Gabriels J; Khan M; Shaban N; D'Amato S; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman B; Patel A; Cheung JW
Heart Rhythm; 2018 Apr; 15(4):496-502. PubMed ID: 29605015
[TBL] [Abstract][Full Text] [Related]
20. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
